These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8825812)

  • 1. Follow-up of three years of treatment with growth hormone and of one post-treatment year, in children with severe growth retardation of intrauterine onset.
    Job JC; Chaussain JL; Job B; Ducret JP; Maes M; Olivier M; Ponte C; Rochiccioli P; Vanderschueren-Lodeweyckx M; Chatelain P
    Pediatr Res; 1996 Feb; 39(2):354-9. PubMed ID: 8825812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation.
    Fjellestad-Paulsen A; Czernichow P; Brauner R; Bost M; Colle M; Lebouc JY; Lecornu M; Leheup B; Limal JM; Raux MC; Toublanc JE; Rappaport R
    Acta Paediatr; 1998 May; 87(5):511-7. PubMed ID: 9641731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth-retarded children. Belgian and French Pediatric Clinics and Sanofi-Choay (France).
    Chatelain P; Job JC; Blanchard J; Ducret JP; Oliver M; Sagnard L; Vanderschueren-Lodeweyckx M
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1454-60. PubMed ID: 8200949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature.
    Kamp GA; Waelkens JJ; de Muinck Keizer-Schrama SM; Delemarre-Van de Waal HA; Verhoeven-Wind L; Zwinderman AH; Wit JM
    Arch Dis Child; 2002 Sep; 87(3):215-20. PubMed ID: 12193430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GH treatment induces sustained catch-up growth in children with intrauterine growth retardation: 7-year results.
    Albanese A; Stanhope R
    Horm Res; 1997; 48(4):173-7. PubMed ID: 9378463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone in the treatment of short stature in young children with intrauterine growth retardation.
    Czernichow P; Fjellestad-Paulsen A
    Horm Res; 1998; 49 Suppl 2():23-7. PubMed ID: 9730668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone treatment in children with Noonan's syndrome: four year results of a partly controlled trial.
    Noordam C; Van der Burgt I; Sengers RC; Delemarre-van de Waal HA; Otten BJ
    Acta Paediatr; 2001 Aug; 90(8):889-94. PubMed ID: 11529537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short stature associated with intrauterine growth retardation: final height of untreated and growth hormone-treated children.
    Coutant R; Carel JC; Letrait M; Bouvattier C; Chatelain P; Coste J; Chaussain JL
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1070-4. PubMed ID: 9543119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up height after discontinuation of growth hormone treatment in children with intrauterine growth retardation.
    Darendeliler F; Bundak R; Eryilmaz SK; Günöz H; Baş F; Saka N
    J Pediatr Endocrinol Metab; 2002 Jun; 15(6):795-800. PubMed ID: 12099389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
    Lampit M; Hochberg Z
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological growth hormone secretion and response to growth hormone treatment in children with short stature and intrauterine growth retardation.
    Stanhope R; Ackland F; Hamill G; Clayton J; Jones J; Preece MA
    Acta Paediatr Scand Suppl; 1989; 349():47-52; discussion 53-4. PubMed ID: 2750531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the growth response to growth hormone in patients with intrauterine growth retardation.
    Frank GR; Cheung PT; Horn JA; Alfaro MP; Smith EP; Chernausek SD
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):679-85. PubMed ID: 8759180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved final height with long-term growth hormone treatment in Noonan syndrome.
    Osio D; Dahlgren J; Wikland KA; Westphal O
    Acta Paediatr; 2005 Sep; 94(9):1232-7. PubMed ID: 16203673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone.
    de Muinck Keizer-Schrama S; Van den Broeck J; Sas T; Hokken-Koelega A
    Horm Res; 1999; 51 Suppl 3():127-31. PubMed ID: 10592457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of growth hormone dose on bone maturation and puberty in children with idiopathic short stature.
    Crowe BJ; Rekers-Mombarg LT; Robling K; Wolka AM; Cutler GB; Wit JM;
    J Clin Endocrinol Metab; 2006 Jan; 91(1):169-75. PubMed ID: 16263828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final height gain by GH therapy in children with idiopathic short stature is dose dependent.
    Wit JM; Rekers-Mombarg LT;
    J Clin Endocrinol Metab; 2002 Feb; 87(2):604-11. PubMed ID: 11836292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A; Simon D; Czernichow P
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.